Home > Insider Trading > Filing (0001140361-17-034317)

Filing Details

Accession Number:: 0001140361-17-034317
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-05 17:50:51
Reporting Period:: 2017-08-31

Accepted Time:: 2017-09-05 16:50:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	Insurance Agents, Brokers & Service (6411)	461282634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1569128	D Michael Hershberger	C/O Health Insurance Innovations, Inc. 15438 North Florida Ave., Suite 201 Tampa FL 33613	Cfo, Secretary And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2017-08-31	2,500	$34.81	94,569	No	4	S	Direct
Class A Common Stock	Disposition	2017-09-01	400	$28.36	94,169	No	4	S	Direct
Class A Common Stock	Disposition	2017-09-01	3,300	$29.10	90,869	No	4	S	Direct
Class A Common Stock	Disposition	2017-09-01	100	$30.45	90,769	No	4	S	Direct
Class A Common Stock	Disposition	2017-09-01	800	$32.09	89,969	No	4	S	Direct
Class A Common Stock	Disposition	2017-09-01	400	$33.74	89,569	No	4	S	Direct
Class A Common Stock	Acquisiton	2017-09-01	15,000	$10.45	104,569	No	4	M	Direct
Class A Common Stock	Disposition	2017-09-01	4,659	$28.97	99,910	No	4	D	Direct
Class A Common Stock	Disposition	2017-09-01	3,597	$28.97	96,313	No	4	S	Direct
Class A Common Stock	Acquisiton	2017-09-01	15,000	$4.95	111,313	No	4	M	Direct
Class A Common Stock	Disposition	2017-09-01	2,207	$32.02	109,106	No	4	D	Direct
Class A Common Stock	Disposition	2017-09-01	4,450	$32.02	104,656	No	4	S	Direct
Class A Common Stock	Acquisiton	2017-09-01	7,500	$4.99	112,156	No	4	M	Direct
Class A Common Stock	Disposition	2017-09-01	1,113	$33.81	111,043	No	4	D	Direct
Class A Common Stock	Disposition	2017-09-01	2,222	$33.81	108,821	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2017-09-01	15,000	$0.00	15,000	$10.45
Common Stock	Stock Appreciation Rights	Disposition	2017-09-01	15,000	$0.00	15,000	$4.95
Common Stock	Stock Appreciation Rights	Disposition	2017-09-01	7,500	$0.00	7,500	$4.99

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2021-05-21	No	4	M	Direct
15,000	2022-07-01	No	4	M	Direct
22,500	2022-09-16	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Appreciation RIghts	$5.20		2023-09-16	40,972	40,972	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-09-16	40,972	40,972	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.75 to $34.90, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Sale made pursuant to 10b5-1 plan executed on November 18, 2016.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.85 to $28.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.0990, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.65 to $33.80, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
These stock-settled stock appreciation rights were granted under the Long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.00, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.15, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.80 to $33.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.